hers stock - Search News

Hims & Hers Stock Plummets. Wegovy Shortage Is Over.

Hosted on MSN · 2d

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Investopedia on MSN · 2d

Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Eli Lilly’s Wegovy and Novo Nordisk’s Ozempic has been resolved.

The Motley Fool on MSN · 2d

Why Hims & Hers Health Stock Is Plummeting Today

Shares of Hims & Hers Health (NYSE: HIMS) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as much as 26.1% earlier in the day. The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.

1d

HIMS Earnings Preview: Will The Stock Rebound After 25% Drop?

Hims & Hers Health (NYSE:HIMS) is set to report its earnings on Monday, Feb 24 after market close. HIMS stock plunged over 25 ...

9h

Hims & Hers Declines - How The GLP-1 Market Shift Affects Growth

Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...

SchaeffersResearch.com2d

Hims and Hers Stock Drops Weight as Earnings Loom

Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...

3d

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Axios Vitals on MSN2d

Ozempic and Wegovy shortage ends, setting up weight loss drug showdown

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results